ChiCTR2100047571 版本V1.0 版本创建时间2022/01/11 19:28:04 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100047571 

最近更新日期:

Date of Last Refreshed on:

2021-06-20 21:27:10 

注册时间:

Date of Registration:

2021-06-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于恶心呕吐风险评估的标准化治疗策略 对妇科患者术后恶心呕吐的影响

Public title:

Effect of standardized treatment strategy based on risk assessment of nausea and vomiting on postoperative nausea and vomiting in gynecological patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

麻醉学

Scientific title:

Anesthesiology

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

马文静 

研究负责人:

姚卫东 

Applicant:

Wenjing Ma 

Study leader:

Weidong Yao 

申请注册联系人电话:

Applicant telephone:

18214716937

研究负责人电话:

Study leader's
telephone:

18214716938

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

docmwj@163.com

研究负责人电子邮件:

Study leader's E-mail:

docmwj@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

皖南医学院弋矶山医院

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省芜湖市镜湖区赭山西路2号

研究负责人通讯地址:

安徽省芜湖市镜湖区赭山西路2号

Applicant address:

No.2 Zheshan West Road, Jinghu District, Wuhu City, Anhui Province

Study leader's address:

No.2 Zheshan West Road, Jinghu District, Wuhu City, Anhui Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

皖南医学院弋矶山医院

Applicant's institution:

Yijishan Hospital of Wannan Medical College

研究负责人所在单位:

皖南医学院弋矶山医院

Affiliation of the Leader:

Yijishan Hospital of Wannan Medical College

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2021)伦审新第(06)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

皖南医学院弋矶山医院科研与新技术伦理委员会

Name of the ethic committee:

Scientific Research and New Technology of Wannan Medical College Yijishan Hospital IRB

伦理委员会批准日期:

Date of approved by ethic committee:

2021-04-09 00:00:00

伦理委员会联系人:

鲁卫华

Contact Name of the ethic committee:

WeiHua Lu

伦理委员会联系地址:

安徽省芜湖市镜湖区赭山西路2号

Contact Address of the ethic committee:

No.2 Zheshan West Road, Jinghu District, Wuhu City, Anhui Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

18214716938

伦理委员会联系人邮箱:

Contact email of the ethic committee:

docqyp@163.com

研究实施负责(组长)单位:

皖南医学院弋矶山医院

Primary sponsor:

Yijishan Hospital of Wannan Medical College

研究实施负责(组长)单位地址:

安徽省芜湖市镜湖区赭山西路2号

Primary sponsor's address:

No.2 Zheshan West Road, Jinghu District, Wuhu City, Anhui Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽

市(区县):

芜湖

Country:

China

Province:

Anhui

City:

Wuhu

单位(医院):

皖南医学院弋矶山医院

具体地址:

镜湖区赭山西路2号

Institution
hospital:

Yijishan Hospital of Wannan Medical College

Address:

2 Zheshan Road West, Jinghu District

经费或物资来源:

皖南医学院弋矶山医院

Source(s) of funding:

Yijishan Hospital of Wannan Medical College

研究疾病:

术后恶心呕吐  

Target disease:

PONV

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

本研究将基于恶心呕吐风险评估的标准化管理策略,探讨该策略应用的可行性及其对我院妇科手术患者恶心呕吐发生率的影响。  

Objectives of Study:

This study will be based on the standardized management strategy of nausea and vomiting risk assessment to explore the feasibility of the application of the strategy and its impact on the incidence of nausea and vomiting in gynecological surgery patients in our hospital.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

入组病例需要同时满足以下4个条件。
1、签订知情同意书;2、年龄18-65岁;3、择期全麻下行腹腔镜妇科手术患者;4、ASA Ⅰ或Ⅱ级

Inclusion criteria

The enrolled cases need to meet the following four conditions at the same time.

1. Sign informed consent; 2. They were 18-65 years old; 3. Laparoscopic gynecological surgery under general anesthesia was performed; 4. ASA grade I or II

排除标准:

1、 急诊手术患者;2、 胃肠道疾病患者;3、 术前24小时内服用过止吐药物;4、 对药物过敏者。

Exclusion criteria:

1. Emergency operation patients; 2. Patients with gastrointestinal diseases; 3. Antiemetic drugs were taken within 24 hours before operation; 4. Allergic to drugs.

研究实施时间:

Study execute time:

From 2021-07-01 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-07-01 00:00:00 To 2021-12-31 00:00:00

干预措施:

Interventions:

组别:

1组

样本量:

0

Group:

Group 1

Sample size:

干预措施:

标准化治疗

干预措施代码:

Intervention:

standard treatment

Intervention code:

组别:

2组

样本量:

0

Group:

Group 2

Sample size:

干预措施:

传统治疗

干预措施代码:

Intervention:

traditional treatment

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽 

市(区县):

芜湖 

Country:

China

Province:

Anhui

City:

Wuhu

单位(医院):

皖南医学院弋矶山医院 

单位级别:

三级甲等 

Institution
hospital:

Yijishan Hospital of Wannan Medical College

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

恶心呕吐发生率

指标类型:

主要指标

Outcome:

incidence of nausea and vomiting

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Null

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

计算机产生的随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

a computer-generated random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2022.06 临床试验公共管理平台 Clinical Trial Management Public Platform (medresman.org.cn)

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

2022.06 Clinical trial management public platform (medresman. Org. CN)

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表(Case Record Form, CRF)

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-06-20 21:27:10